PDCD1 and acute myeloid leukemia: NK-cells and blast cells do express PD-1 and PD-L1, respectively and blockade using a PD-1 monoclonal antibody or scFv enhanced NK cell cytotoxicity against AML targets in vitro, although appears to be most relevant for resting rather than cytokine activated NK cells [181].